17,292
Participants
Start Date
July 2, 2018
Primary Completion Date
March 31, 2021
Study Completion Date
March 31, 2021
Typhoid Conjugate Vaccine
Typbar TCV Vi-TT (Vi capsular polysaccharide conjugated with tetanus toxoid protein) manufactured by Bharat Biotech International Limited
D. Y. Patil Medical College and Hospital, Nerul, Navi Mumbai
Dr. Joshi's Central Clinical Microbiology Laboratory, Vashi, Navi Mumbai
Dr. Yewale Multispecialty Hospital for Children, Vashi, Navi Mumbai
Mahatma Gandhi Memorial (MGM) New Bombay Hospital, Vashi, Navi Mumbai
Mathadi Hospital Trust, Koparkharaine, Navi Mumbai
Navi Mumbai Municipal Corporation (NMMC) General Hospital, First Referral Unit (FRU), Vashi, Navi Mumbai
Centers for Disease Control and Prevention
FED
World Health Organization
OTHER
National Institute of Cholera and Enteric Diseases, India
OTHER
Bill and Melinda Gates Foundation
OTHER
Stanford University
OTHER